Groups | Drug concentration (%, w/w) | Hepatic index (%) | Hepatic protein (g/g liver tissue) | Serum ALT activity (U/L) |
---|---|---|---|---|
Normal mice | Â | Â | Â | Â |
Control ND | - | 6.59 ± 0.10 | 0.138 ± 0.003 | 36.50 ± 3.61 |
SAqFSC-P/ND | 1 | 6.76 ± 0.13 | 0.131 ± 0.003 | 27.60 ± 0.72a |
 | 9 | 6.91 ± 0.13 | 0.140 ± 0.004 | 30.33 ± 2.41 |
PAqFSC-P/ND | 1 | 6.73 ± 0.11 | 0.146 ± 0.002a | 32.80 ± 1.63 |
 | 9 | 7.16 ± 0.17b | 0.155 ± 0.003b | 32.00 ± 1.81 |
Bicyclol/ND | 0.025 | 6.69 ± 0.11 | 0.153 ± 0.002b | 26.00 ± 1.67a |
Hypercholesterolemic mice | Â | Â | Â | Â |
Control ND | - | 6.43 ± 0.77 | 0.133 ± 0.004 | 36.18 ± 2.17 |
Control HCBD | - | 7.19 ± 0.13b | 0.150 ± 0.002a | 50.09 ± 5.81a |
SAqFSC-P/HCBD | 1 | 7.17 ± 0.11 | 0.140 ± 0.005c | 47.26 ± 3.58 |
 | 3 | 7.06 ± 0.16 | 0.153 ± 0.003 | 46.32 ± 2.52 |
PAqFSC-P/HCBD | 1 | 6.99 ± 0.16 | 0.147 ± 0.004 | 47.31 ± 3.38 |
 | 3 | 7.04 ± 0.13 | 0.156 ± 0.003 | 43.60 ± 3.90 |
Bicyclol/HCBD | 0.025 | 7.25 ± 0.06 | 0.149 ± 0.003 | 29.30 ± 1.52c |